Understanding the progression of early atrophic lesions in age-related macular degeneration
Progression of Early Atrophic Lesions in Age-related Macular degeneration
This study is looking at how early age-related macular degeneration (AMD) changes over time to find ways to help prevent serious vision loss, and it's for people who want to understand their condition better and improve their quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10875371 on NIH RePORTER |
What this research studies
This research investigates the progression of early atrophic age-related macular degeneration (AMD), focusing on a critical time window where interventions may prevent significant vision loss. By utilizing advanced retinal imaging and functional testing, the study aims to identify microstructural changes and assess how these changes impact patients' quality of life. Patients will be monitored over time to gather comprehensive data on disease progression and risk factors, which could inform targeted therapies to preserve vision.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early atrophic age-related macular degeneration.
Not a fit: Patients with advanced stages of age-related macular degeneration or those without any form of AMD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that prevent vision loss in patients with early atrophic AMD.
How similar studies have performed: Previous research has shown promise in understanding AMD progression, but this specific focus on early atrophic lesions represents a novel approach.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Schmitz-Valckenberg, Steffen — University of Utah
- Study coordinator: Schmitz-Valckenberg, Steffen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.